Genetic research
We at Medical Karadje Health Information Center care about making informed choices for our patients. That's why we always try to find information about innovative methods of diagnosis and treatment. Here, we want to introduce you to the latest genetic tests that can be of great help for diagnosis and prevention as well as for determining the right treatment plan.
NM Genomics is a specialty medical group practice with more than 10 years of experience in the medical field and an individual approach to each patient.
The efforts of NM Genomics are aimed at introducing the latest medical technologies for the benefit of the patient. By providing innovative medical products and services of the highest quality, we strive to provide our customers with access to the highest standards in healthcare.
The company's activity is focused on integrating globally established genetic research in the field of prenatal monitoring into the Bulgarian market, as well as research for monitoring and evaluating the effectiveness of therapy in patients with oncological diseases according to their individual disease profile, determining genetic predisposition in the field of ophthalmology, and genetic markers related to mental health.
Thanks to our partnerships with leading companies and service providers across Europe and the USA in the field of molecular genetic diagnostics, we are able to shorten the distance between the Bulgarian patient and medical services of the highest European and global standard.
[wp_call_button btn_text="CALL NOW!" btn_color="#fa1919" hide_phone_icon="no"]
Below, you can review all the key research present in NM Genomix's portfolio and learn how they work. The research covers the following areas:
- Oncology;
- Prenatal care;
- Psychiatry;
- Lifestyle tests including personalized information about your microbiome, skincare, diet, and fitness exercises;
Oncology
MAINTRAC
The Myne-Track test is a blood test that examines how specific treatments (chemotherapies) would affect a particular patient's body. Myne-Track is applicable to patients with all types of solid tumors of epithelial origin. The results are individual for each patient and help in prescribing the most effective therapy even before treatment has begun.
Type: blood sample Results: Up to 5 business days Laboratory Dr. Pachmann Laboratory, Bayreuth
Read more about the study here!
ONCONEXT
OncoNEXT is used to analyze 67 key genes associated with various types of cancer, helping to identify genetic mutations that can guide targeted therapies. Through such testing, doctors receive information that aids in personalizing treatment according to the patient's genetic profile. This test is applied both to patients with a confirmed diagnosis and to individuals without a diagnosis but with a family history and the possibility of inheriting genetic mutations.
Type: blood sample Results: 15 business days Laboratory Centogene, Germany
Read more about the study here!
OncoNEXT Plus
OncoNext Plus expands the analysis to 118 key genes associated with all types of cancer, helping to identify genetic mutations that can guide targeted therapies. Through such testing, physicians receive information that supports the personalization of treatment according to the patient's genetic profile. This test is applied both to diagnosed patients and to individuals without a diagnosis but with a family history and the possibility of inheriting genetic mutations.
Type: blood sample Results: 15 business days Laboratory Centogene, Germany
Read more about the study here!
Histopathological analysis – second opinion
Histopathological analysis – a second opinion is a test that can confirm, supplement, or reject an initial diagnosis. Histopathological examination allows for a clear analysis of the disease's progression. The test provides information about the malignancy grade and calculates the exact type and origin of the formation. Through histopathological analysis, the patient and their doctor understand the exact characteristics of the condition, which enables the selection of precise and effective therapy.
Type: tissue biopsy and slides Results: 7-8 business days Laboratory Institute of Clinical Pathology, Germany
Read more about the study here!
OncoSeek
The Oncoseek test is designed for screening and aiding in the early identification of cancers by integrating the measurement of a panel of 7 selected protein tumor markers (AFP, CA125, CA15-3, CA19-9, CA72-4, CEA, and CYFRA21-1) and the individual's clinical information. The examination of these markers provides information and is the basis for detecting the nine most common cancers: Lymphoma; Esophageal cancer; Liver cancer; Breast and ovarian cancer; Pancreatic cancer; Stomach cancer; Colon cancer; Lung cancer.
Type: blood sample Results: 5 business days Laboratory Labor Mönchengladbach MVZ Dr Stein
Read more about the study here!
MammaPrint & BluePrint
The MammaPrint & BluePrint study is used to assess the risk of breast cancer recurrence by analyzing the expression of a total of 150 genes associated with disease progression. The test is applicable to all hormone receptor statuses, tumor sizes up to 5 cm, and up to 3 affected lymph nodes. The report categorizes the risk as low or high, which helps physicians determine the need for additional chemotherapy after surgery. This allows patients to receive more personalized treatment and avoid unnecessary therapy if the risk of recurrence is low.
Type: tissue biopsy Results: 10 business days Laboratory Agendia Laboratory, USA
Read more about the study here!
OncoDEEP
The OncoDEEP study is designed for in-depth molecular analysis of tumor samples, including DNA and RNA sequencing of 638 genes, as well as evaluation of genetic markers such as MSI, TMB, SNV, HRD, INDEL, and TERT promoter mutations. It provides information on genetic mutations and the expression of 22 RNAs, which aids in selecting personalized therapies for the treatment of oncological diseases.
The test is applicable to solid tumors in stages 3 and 4.
Type: tissue biopsy and slides Getting results: 10 business days Laboratory OncoDNA Laboratory, Belgium
Read more about the study here!
OncoSELECT
The OncoSelect study provides an analysis of the molecular profile of a blood sample, identifying mutations and genetic alterations in 70 key cancer-related genes. It also assesses biomarkers, which helps physicians select the most appropriate targeted therapies and immunotherapies. Through this analysis, the approach to individualized cancer patient treatment is optimized.
Type: blood sample Getting results: 10 business days Laboratory OncoDNA Laboratory, Belgium
Read more about the study here!
GenomeBreast
This test assesses genetic family predisposition to breast and ovarian cancer by screening for BRCA1 and BRCA2 mutations. The main benefits of Genome Breast for patients with a confirmed diagnosis include guiding treatment toward targeted therapy, avoiding unnecessary treatments, and finding the most appropriate solution. For individuals without a diagnosis, the test can help guide them toward a specific screening and prevention regimen. The method used to analyze the sample is the most advanced biotechnological method, known as next-generation sequencing (NGS), which provides 100% accuracy in the results. Once the results are received, a consultation is conducted with a genetic expert from NM Genomix.
Type: blood sample Getting results: 15 business days Laboratory Centogene Laboratory, Germany
Read more about the study here!
GenomeBreast+
The GenomeBreast+ test is used to assess the genetic risk of developing breast and ovarian cancer by analyzing 28 genes associated with these diseases. The test also includes an assessment of polymorphisms that influence susceptibility to cancer, as well as genetic variations associated with treatment response and prognosis. This allows for a more comprehensive understanding of individual risk and supports decision-making regarding prevention, early detection, and treatment. The method used to analyze the sample is the most advanced biotechnological method, known as next-generation sequencing (NGS), which provides 100% accuracy in the results. Once the results are received, a consultation is conducted with a genetic expert from NM Genomix.
Type: blood sample Getting results 15 business days Laboratory Centogene Laboratory, Germany
Read more about the study here!
Prenatal care
Panorama
Panorama is a non-invasive prenatal test used to screen for the most common genetic abnormalities in the fetus during pregnancy. Panorama is one of the most reliable and effective methods of prenatal diagnosis because it has an accuracy rate of over 99.9% and is completely safe for both the baby and the mother. The advantage of Panorama is that it can be performed as early as the 9th week of gestation, giving families the opportunity to make an informed choice about the future. An interesting fact is that Panorama provides you (if you wish) with free information about the sex of your unborn baby.
Type: blood sample Getting results 7 business days Laboratory NATERA, USA
Read more about the study here!
TEST OVER FATHERHOOD
The importance of information regarding the biological father has not only a moral and ethical side but also one that affects the child's future health. Many diseases have a genetic factor, and in potential cases requiring transplantation or blood transfusions, biological relatives usually have the strongest compatibility. NM Genomix offers paternity testing not only for born children but also during pregnancy (from the 8th gestational week).
Upon the birth of a child: Type: Buccal swab Getting results: 7 business days Laboratory DNA Diagnostic Center, Fairfield, Ohio, USA
During pregnancy: Type: blood sample Getting results: 15 business days Laboratory DNA Diagnostic Center, Fairfield, Ohio, USA
Read more about the study here!
Psychiatry
GENPRO PGX
GenPro is a pharmacogenetic test that analyzes a specific patient's body's response to the most commonly used medications in the treatment of psychiatric conditions. The test is suitable for both adults and children with conditions such as depression, anxiety, schizophrenia, autism, Alzheimer's, epilepsy, and many others. GenPro helps to avoid the “trial and error” method and consequently to prescribe the most appropriate therapy.
Type: Buccal swab Getting results: 7 calendar days Laboratory:Genomind, Pennsylvania, USA
Read more about the study here!
Lifestyle tests
MICROBIOME PASSPORT
Everyone's microbiome is unique and represents the collection of microorganisms that inhabit our gastrointestinal tract. It has a direct connection to our immunity, metabolic processes, mental health, and even our cardiovascular system. A reduced amount of beneficial gut bacteria can lead to weight gain, insulin resistance, constipation, diarrhea, autoimmune diseases, and an increased inflammatory response. A „Microbiome Passport” is a comprehensive genetic analysis of over 1500 species of bacteria, including personalized recommendations from a specialist and advice on how to improve your health with a proper diet.
Type: Stool sample Getting results 4-6 weeks Laboratory:Medical University of Vienna, Austria
Read more about the study here!
LifeGenomix is an exclusive series of genetic tests for personalized nutrition, sports, and skin care, tailored to the individual needs and unique DNA of each person. It is a response to the demands of modern, young, and dynamic individuals who strive for continuous self-improvement and enhancement of their lifestyle through the most innovative scientific advancements in health and appearance care. The tests from the LifeGenomix line provide an excellent foundation for building an individualized plan for nutrition, sports, skin care, and achieving overall balance.
Type: buccal mucosal swab Getting results 6 weeks Laboratory Dynamics DNA Lab, Missouri, USA
Read more about the study here!
